BioCentury
ARTICLE | Clinical News

DTC 101: Began Canadian enrollment in a Phase III trial

November 7, 1994 8:00 AM UTC

DepoTech Corp., La Jolla, Calif. Product: DTC 101 formulation of cytarabine chemotherapeutic in the DepoFoam lipid-based drug delivery system Indication: Neoplastic meningitis caused by cancer metasta...